ClinicalTrials.gg
Not yet recruitingNCT07874061SEL-ARUpdated Oct 14, 2026

Augmented Reality Virtual Patient Simulation to Enhance Social-Emotional Competence and Self-Efficacy in Nursing Students

An interventional study of VP-I and VP-AR in Nursing Education, Social-Emotional Learning and Self-Efficacy, sponsored by Chang Gung Memorial Hospital. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Other

Updated Oct 14, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized crossover teaching practice study evaluates whether smart technology and media-integrated friendly childbirth education can improve nursing students' social-emotional competence and self-efficacy. All participants will receive both instructional conditions: virtual patient-based augmented reality learning (VP-AR) and VP-I. Students will be randomly assigned to one of two intervention sequences: VP-I followed by VP-AR (AB sequence) or VP-AR followed by VP-I (BA sequence). Outcomes will be assessed using validated questionnaires, scenario-based learning performance, and students' learning experiences.

Read the detailed description

This randomized crossover teaching practice study will be conducted among nursing students enrolled in a friendly childbirth course. All eligible participants will receive both instructional conditions, VP-I and virtual patient-based augmented reality learning (VP-AR), during two prespecified instructional periods. Participants will be randomly assigned using computer-generated stratified block randomization to one of two intervention sequences.

In the AB sequence, participants will receive VP-I during Period 1 followed by VP-AR during Period 2. In the BA sequence, participants will receive VP-AR during Period 1 followed by VP-I during Period 2. The primary outcomes are changes in students' social-emotional learning literacy and general self-efficacy. Secondary outcomes include emotion regulation strategies, scenario-based learning performance, and course learning experience.

Outcome assessments will be conducted at the prespecified baseline, period-specific, and post-intervention assessment points according to the study protocol. The study will compare participants' outcomes between the VP-I and VP-AR instructional conditions while accounting for intervention sequence and period effects.

02

Conditions studied

  • Nursing Education
  • Social-Emotional Learning
  • Self-Efficacy

Keywords

  • Friendly Childbirth
  • Smart Technology
  • Virtual Patient
  • Augmented Reality
  • Nursing Students
  • Randomized Crossover Trial
03

In context

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,091 studies on the registry; 237 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergraduate nursing students enrolled in the friendly childbirth course.
  • Aged 18 years or older.
  • Able to understand the study information and provide informed consent.
  • Able to participate in the course learning activities and complete the study assessments.

Exclusion criteria

Exclusion Criteria:

  • Students who do not provide informed consent.
  • Students who withdraw consent before completing the study procedures.
  • Students who are unable to complete the study assessments because of circumstances that substantially interfere with participation.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Sequence AB: VP-I Followed by VP-AR

    Participants receive VP-I during Period 1 followed by VP-AR during Period 2.

    Behavioral: VP-I · Behavioral: VP-AR

  • Experimental
    Sequence BA: VP-AR Followed by VP-I

    Participants receive VP-AR during Period 1 followed by VP-I during Period 2.

    Behavioral: VP-I · Behavioral: VP-AR

Interventions

  • BehavioralVP-I

    VP-I is an instructional condition used in the friendly childbirth course. Participants complete the approved learning activities and teaching scenarios specified in the study protocol.

  • BehavioralVP-AR

    VP-AR is a virtual patient-based augmented reality instructional condition integrated into the friendly childbirth course. Participants complete the approved smart technology-supported learning activities and teaching scenarios specified in the study protocol.

06

What researchers measure

Primary outcomes

  1. Difference in Change in Social-Emotional Learning Literacy Between VP-I and VP-AR Periods

    Change in students' social-emotional learning literacy measured by the 21-item Social-Emotional Learning Literacy Scale for College Students. The total score is calculated according to the scale scoring instructions, with higher scores indicating higher social-emotional learning literacy.

    Time frame: From baseline assessment at Week 4 through the end of each intervention period during Weeks 5 to 17

  2. Difference in Change in General Self-Efficacy Between VP-I and VP-AR Periods

    Change in students' general self-efficacy measured by the 10-item General Self-Efficacy Scale. The total score is calculated according to the scale scoring instructions, with higher scores indicating higher general self-efficacy.

    Time frame: From baseline assessment at Week 4 through the end of each intervention period during Weeks 5 to 17

Secondary outcomes

  1. Change in Emotion Regulation Strategies

    Change in students' emotion regulation strategies measured by the 15-item Emotion Regulation Strategies Scale for College Students. Subscale and total scores are calculated according to the scale scoring instructions.

    Time frame: From baseline assessment at Week 4 through the end of each intervention period during Weeks 5 to 17

  2. Scenario-Based Learning Performance

    Students' performance in friendly childbirth learning scenarios, assessed using system-recorded learning performance indicators, including scenario completion, response accuracy, and related task performance.

    Time frame: During the two intervention periods from Week 5 through Week 17

  3. Course Learning Experience

    Students' perceived learning experience during the friendly childbirth course, assessed using the course learning experience questionnaire and written learning reflections.

    Time frame: At the post-intervention assessment at Week 18

07

Study locations

No study locations are listed for this record.

08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07874061
Collaborators
Chang Gung University of Science and Technology
Responsible party
Sponsor
First posted
Oct 14, 2026
Start date
Nov 2, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Oct 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion